Clinical Trials Browser

OTHER × Prostatic Neoplasms × erdafitinib × Clear all

NCT04754425 2026-02-06

Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer

Phase 2 Terminated

Prostatic Neoplasms